The Effects of Short Message Notifications on Middle-Aged Diabetic Patients
Primary Purpose
Type2 Diabetes Mellitus
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Informative messages
Sponsored by
About this trial
This is an interventional prevention trial for Type2 Diabetes Mellitus focused on measuring Diabetes mellitus, Public health
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of Type 2 Diabetes Mellitus (T2DM) between the last 1 and 10 years
- Being aged between 40 and 64 years old,
- Is treated for a minimum of 1 year with at least one oral antidiabetic drug.
Exclusion Criteria:
- Clinical diagnosis of T2DM for less than 1 year or more than 10 years.
- Those who have had surgery or a cardiac event in the last 3 months or during the investigation.
- Those under 40 and over 64 years of age.
- Patients with T2DM that have not been treated with oral antidiabetic medication.
- Volunteers who once did not participate in the control examinations in both groups were excluded from the evaluation.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
SMS Group
Control Group
Arm Description
In addition to traditional treatment received three to four informative SMS messages per week during the 6-month period
Followed in accordance with the traditional treatment schedule
Outcomes
Primary Outcome Measures
Fasting blood glucose
After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).
Change from Baseline Fasting blood glucose at 3 months
After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).
Change from Baseline Fasting blood glucose at 6 months
After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).
Glycated hemoglobin A (HbA1c)
In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method.
Change from Baseline of Glycated hemoglobin A (HbA1c) at 3 months
In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method
Change from Baseline of Glycated hemoglobin A (HbA1c) at 6 months
In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method
Physical Activity level
The International Physical Activity Questionnaire (IPAQ) was used to evaluate the physical activity level of the participants at the beginning of the study.
This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.
Change from Baseline Physical Activity at 3 months
The International Physical Activity Questionnaire (IPAQ) was used to evaluate the physical activity level of the participants at at 3 months after the beginning of the study.
This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.
Change from Baseline Physical Activity at 6 months
The International Physical Activity Questionnaire (IPAQ) was used to evaluate the change in physical activity level of the participants at at 6 months after the beginning of the study.
This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.
Drug Adherence
The Morisky Medication Adherence Scale (MMAS-8) was used to assess the compliance of patients with drug treatment.
If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.
Change from Baseline Drug Adherence at 3 months
The Morisky Medication Adherence Scale was used to assess the compliance of patients with drug treatment.
If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.
Change from Baseline Drug Adherence at 6 months
The Morisky Medication Adherence Scale (MMAS-8) was used to assess the compliance of patients with drug treatment.
If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.
Quality of Life Assessed by SF-36v2
The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.
Change from Baseline Quality of Life Assessed by SF-36v2 at 3 months
The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.
Change from Baseline Quality of Life Assessed by SF-36v2 at 6 months
The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.
Secondary Outcome Measures
Baseline blood pressure
The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.
Change from Baseline blood pressure at 3 months
The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.
Change from Baseline blood pressure at 6 months
The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.
Baseline heart rate
The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.
Change from Baseline heart rate at 3 months
The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.
Change from Baseline heart rate at 6 months
The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.
Baseline Body Mass Index
The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:
BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.
Change from Baseline Body Mass Index at 3 months
The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:
BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.
Change from Baseline Body Mass Index at 6 months
The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:
BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.
Baseline body fat ratios
The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Change from Baseline Body Fat Ratios at 3 Months
The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Change from Baseline Body Fat Ratios at 6 Months
The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Baseline waist/hip ratio
The volunteers waist and hip circumference and waist/hip ratio were measured by tape measure after 8 hours of fasting in the morning with thin clothes on them.
Waist circumference (cm) was measured at the level of the umbilicus and hip circumference (cm) at the level of the femur trochanter major.
Waist/hip ratio (WHR) were were calculated as follows
waist/hip ratio= waist circumference / hip circumference
Change from Baseline waist/hip ratio at 3 Months
The volunteers waist and hip circumference and waist/hip ratio were measured by tape measure after 8 hours of fasting in the morning with thin clothes on them.
Waist circumference (cm) was measured at the level of the umbilicus and hip circumference (cm) at the level of the femur trochanter major.
Waist/hip ratio (WHR) were were calculated as follows
waist/hip ratio= waist circumference / hip circumference
Baseline Diet and Nutritional Habits
The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.
Change from Baseline Diet and Nutritional Habits at 3 months
The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.
Change from Baseline Diet and Nutritional Habits at 6 months
The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.
Baseline Energy Intake
From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.
Change from Baseline Energy Intake at 3 months
From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.
Change from Baseline Energy Intake at 6 months
From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04733612
Brief Title
The Effects of Short Message Notifications on Middle-Aged Diabetic Patients
Official Title
Effects of Short-Message Notifications on Medication Adherence, Physical Activity and Fasting Blood Glucose Control and Correlation of These With the Health-Related Quality of Life in Mid-aged Diabetic Patients
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
June 30, 2016 (Actual)
Primary Completion Date
December 20, 2017 (Actual)
Study Completion Date
February 26, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Istanbul University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The objective of our study was to assess awareness-raising of medication adherence (MA), physical activity (PA), fasting blood glucose (FBG), and glycated hemoglobin A (HbA1c) values by providing information on diabetes via short message (SMS) technology.
Detailed Description
The study investigates T2DM patients who have not had surgery or cardiac event in the last 3 months, between the ages of 40 and 64 years, with T2DM diagnosis between the last 1 and 10 years and oral antidiabetic therapy for at least 1 The study design is a single-blinded randomized, controlled study, and was conducted in the Diabetes Polyclinic of the Istanbul University Medical Faculty Hospital.
Patients randomly assigned to the intervention group, in addition to traditional treatment received three to four informative SMS messages per week during the 6-month period, while the control group was followed in accordance with the traditional treatment schedule.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type2 Diabetes Mellitus
Keywords
Diabetes mellitus, Public health
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
125 (Actual)
8. Arms, Groups, and Interventions
Arm Title
SMS Group
Arm Type
Experimental
Arm Description
In addition to traditional treatment received three to four informative SMS messages per week during the 6-month period
Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Followed in accordance with the traditional treatment schedule
Intervention Type
Other
Intervention Name(s)
Informative messages
Intervention Description
In addition to their standard treatments, an informative SMS (text message) on diabetes was sent to the intervention group three to four times a week for six months.
The short messages were in the form of a short sentence for the subject and the predicate. The messages sent have been prepared in such a way that they do not exceed 1 SMS quota and are less than 160 characters on mobile phones.
Primary Outcome Measure Information:
Title
Fasting blood glucose
Description
After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).
Time Frame
Beginning
Title
Change from Baseline Fasting blood glucose at 3 months
Description
After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).
Time Frame
3 months after beginning
Title
Change from Baseline Fasting blood glucose at 6 months
Description
After 8 hours of fasting in the morning, venous whole blood samples were taken to yellow capped tubes for fasting blood glucose (mmol/dL).
Time Frame
6 months after beginning
Title
Glycated hemoglobin A (HbA1c)
Description
In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method.
Time Frame
Beginning
Title
Change from Baseline of Glycated hemoglobin A (HbA1c) at 3 months
Description
In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method
Time Frame
3 months after beginning
Title
Change from Baseline of Glycated hemoglobin A (HbA1c) at 6 months
Description
In the HbA1c evaluation (%), after 8 hours of fasting by volunteers, venous whole blood samples were taken in purple tubes (EDTA) between 08:00 and 10:00 a.m. and evaluated by the HPLC method
Time Frame
6 months after beginning
Title
Physical Activity level
Description
The International Physical Activity Questionnaire (IPAQ) was used to evaluate the physical activity level of the participants at the beginning of the study.
This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.
Time Frame
Beginning
Title
Change from Baseline Physical Activity at 3 months
Description
The International Physical Activity Questionnaire (IPAQ) was used to evaluate the physical activity level of the participants at at 3 months after the beginning of the study.
This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.
Time Frame
3 months from beginning
Title
Change from Baseline Physical Activity at 6 months
Description
The International Physical Activity Questionnaire (IPAQ) was used to evaluate the change in physical activity level of the participants at at 6 months after the beginning of the study.
This measure assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting. The higher scores mean a better outcome.
Time Frame
6 months from beginning
Title
Drug Adherence
Description
The Morisky Medication Adherence Scale (MMAS-8) was used to assess the compliance of patients with drug treatment.
If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.
Time Frame
Beginning
Title
Change from Baseline Drug Adherence at 3 months
Description
The Morisky Medication Adherence Scale was used to assess the compliance of patients with drug treatment.
If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.
Time Frame
3 months after beginning
Title
Change from Baseline Drug Adherence at 6 months
Description
The Morisky Medication Adherence Scale (MMAS-8) was used to assess the compliance of patients with drug treatment.
If the patient scores higher on the scale, they will be assessed as more adherent. If they score lower on the scale, they are presumed to be struggling with non-adherence.
Time Frame
6 months after beginning
Title
Quality of Life Assessed by SF-36v2
Description
The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.
Time Frame
Beginning
Title
Change from Baseline Quality of Life Assessed by SF-36v2 at 3 months
Description
The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.
Time Frame
3 months after beginning
Title
Change from Baseline Quality of Life Assessed by SF-36v2 at 6 months
Description
The Short-Form Health Survey (SF-36v2) is used to asses the quality of life of volunteers'. It has 36 items grouped in 8 dimensions: physical functioning, physical and emotional limitations, social functioning, bodily pain, general and mental health. The higher scores mean a better outcome.
Time Frame
6 months after beginning
Secondary Outcome Measure Information:
Title
Baseline blood pressure
Description
The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.
Time Frame
Beginning
Title
Change from Baseline blood pressure at 3 months
Description
The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.
Time Frame
3 months after beginning
Title
Change from Baseline blood pressure at 6 months
Description
The volunteers' systolic and diastolic blood pressure (mmHg) was measured by a physician through a manual cuff and stethoscope after sitting for at least 5 minutes, from the left arm at the level of the heart, as suggested in the literature.
Time Frame
6 months after beginning
Title
Baseline heart rate
Description
The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.
Time Frame
Beginning
Title
Change from Baseline heart rate at 3 months
Description
The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.
Time Frame
3 Months After Beginning
Title
Change from Baseline heart rate at 6 months
Description
The volunteers' heart rate count was measured by a finger-type pulse oximeter, from the index finger of the right or left hand after resting for at least 5 minutes.
Time Frame
6 Months After Beginning
Title
Baseline Body Mass Index
Description
The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:
BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.
Time Frame
Beginning
Title
Change from Baseline Body Mass Index at 3 months
Description
The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:
BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.
Time Frame
3 months after Beginning
Title
Change from Baseline Body Mass Index at 6 months
Description
The height (cm) of the volunteers was obtained in the morning, after 8 hours of fasting, without shoes, standing upright, by measuring the distance from the top of the head to the floor with a calibrated stadiometer. Body weight (kg) were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Body Mass Index (BMI) is calculated using a person's height and weight as shown in formula:
BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in meter square.
Time Frame
6 months after Beginning
Title
Baseline body fat ratios
Description
The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Time Frame
Beginning
Title
Change from Baseline Body Fat Ratios at 3 Months
Description
The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Time Frame
3 Months After Beginning
Title
Change from Baseline Body Fat Ratios at 6 Months
Description
The body fat ratios were measured in the morning after 8 hours of fasting, with light clothing and bare feet, with a calibrated and valid 'Tanita Body Composition Analyzer TBF-410GS' brand bioelectrical impedance analyzer.
Time Frame
6 Months After Beginning
Title
Baseline waist/hip ratio
Description
The volunteers waist and hip circumference and waist/hip ratio were measured by tape measure after 8 hours of fasting in the morning with thin clothes on them.
Waist circumference (cm) was measured at the level of the umbilicus and hip circumference (cm) at the level of the femur trochanter major.
Waist/hip ratio (WHR) were were calculated as follows
waist/hip ratio= waist circumference / hip circumference
Time Frame
Beginning
Title
Change from Baseline waist/hip ratio at 3 Months
Description
The volunteers waist and hip circumference and waist/hip ratio were measured by tape measure after 8 hours of fasting in the morning with thin clothes on them.
Waist circumference (cm) was measured at the level of the umbilicus and hip circumference (cm) at the level of the femur trochanter major.
Waist/hip ratio (WHR) were were calculated as follows
waist/hip ratio= waist circumference / hip circumference
Time Frame
3 Months after Beginning
Title
Baseline Diet and Nutritional Habits
Description
The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.
Time Frame
Beginning
Title
Change from Baseline Diet and Nutritional Habits at 3 months
Description
The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.
Time Frame
3 Months after Beginning
Title
Change from Baseline Diet and Nutritional Habits at 6 months
Description
The last three days' food intake form is used to collect the information about daily nutritional habits of volunteers'. The amount of food and the frequency are marked.
Time Frame
6 Months after Beginning
Title
Baseline Energy Intake
Description
From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.
Time Frame
Beginning
Title
Change from Baseline Energy Intake at 3 months
Description
From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.
Time Frame
3 months after Beginning
Title
Change from Baseline Energy Intake at 6 months
Description
From the last three days' food intake form the average calories (kcal) of macro and micronutrients are calculated.
Time Frame
6 months after Beginning
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Clinical diagnosis of Type 2 Diabetes Mellitus (T2DM) between the last 1 and 10 years
Being aged between 40 and 64 years old,
Is treated for a minimum of 1 year with at least one oral antidiabetic drug.
Exclusion Criteria:
Clinical diagnosis of T2DM for less than 1 year or more than 10 years.
Those who have had surgery or a cardiac event in the last 3 months or during the investigation.
Those under 40 and over 64 years of age.
Patients with T2DM that have not been treated with oral antidiabetic medication.
Volunteers who once did not participate in the control examinations in both groups were excluded from the evaluation.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Suphi Vehid, Prof. Dr.
Organizational Affiliation
Istanbul University
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Since the start date of the study is before 18 January 2017, individual participant data (IPD) will only be available to other researchers on a reasonable request.
Citations:
PubMed Identifier
35330570
Citation
Tahirbegolli B, Tahirbegolli IA, Cakmak R, Idiz C, Cavdar S, Bagdemir E, Vehid S. Effects of Short-message Notifications on Type 2 Diabetes Management in Middle-aged Turkish Patients: A Randomized Trial. Balkan Med J. 2022 Mar 14;39(2):161-162. doi: 10.4274/balkanmedj.galenos.2021.2021-10-47. No abstract available.
Results Reference
derived
Learn more about this trial
The Effects of Short Message Notifications on Middle-Aged Diabetic Patients
We'll reach out to this number within 24 hrs